Halozyme Therapeutics, Inc. (HALO)
106.92
-0.14
(-0.13%)
USD |
NASDAQ |
Aug 27, 16:00
106.92
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Total Return Level : 106.92 for Aug. 27, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 27, 2026 | 106.92 |
| August 26, 2026 | 107.06 |
| August 25, 2026 | 109.32 |
| August 24, 2026 | 108.64 |
| August 21, 2026 | 108.17 |
| August 20, 2026 | 106.12 |
| August 19, 2026 | 107.62 |
| August 18, 2026 | 104.89 |
| August 17, 2026 | 103.00 |
| August 14, 2026 | 98.66 |
| August 13, 2026 | 100.67 |
| August 12, 2026 | 101.79 |
| August 11, 2026 | 102.62 |
| August 10, 2026 | 102.62 |
| August 07, 2026 | 103.12 |
| August 06, 2026 | 85.76 |
| August 05, 2026 | 83.59 |
| August 04, 2026 | 83.23 |
| August 03, 2026 | 82.27 |
| July 31, 2026 | 82.54 |
| July 30, 2026 | 83.30 |
| July 29, 2026 | 83.28 |
| July 28, 2026 | 83.44 |
| July 27, 2026 | 81.48 |
| July 24, 2026 | 81.93 |
| Date | Value |
|---|---|
| July 23, 2026 | 80.84 |
| July 22, 2026 | 77.82 |
| July 21, 2026 | 78.60 |
| July 20, 2026 | 77.09 |
| July 17, 2026 | 77.81 |
| July 16, 2026 | 77.54 |
| July 15, 2026 | 75.82 |
| July 14, 2026 | 75.05 |
| July 13, 2026 | 76.11 |
| July 10, 2026 | 76.20 |
| July 09, 2026 | 78.62 |
| July 08, 2026 | 80.37 |
| July 07, 2026 | 81.57 |
| July 06, 2026 | 80.78 |
| July 02, 2026 | 79.45 |
| July 01, 2026 | 77.01 |
| June 30, 2026 | 78.27 |
| June 29, 2026 | 77.18 |
| June 26, 2026 | 74.96 |
| June 25, 2026 | 72.64 |
| June 24, 2026 | 71.15 |
| June 23, 2026 | 69.62 |
| June 22, 2026 | 68.99 |
| June 18, 2026 | 68.55 |
| June 17, 2026 | 68.57 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 127.74 |
| Neurocrine Biosciences, Inc. | 155.92 |
| AVITA Medical, Inc. | 10.32 |
| Agenus, Inc. | 7.81 |
| Amgen, Inc. | 654.36 |